End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 EUR | -92.64% | -93.33% | -90.69% |
12:34pm | Acticor Biotech: rebound from the previous day's tumble | CF |
Apr. 25 | Acticor Biotech: Phase 2/3 study fails | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-90.69% | 3.8M | |
-1.90% | 103B | |
+0.19% | 95.71B | |
+1.69% | 22.02B | |
-17.18% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-15.11% | 15.52B | |
+3.58% | 13.86B | |
+34.99% | 12.04B |
- Stock Market
- Equities
- ALACT Stock
- News Acticor Biotech SAS
- Acticor Biotech COVID-19 Drug Shown Safe But Not More Effective Than Placebo in Study